Cart summary

You have no items in your shopping cart.

Dasatinib derivative 1

SKU: orb3028203

Description

Dasatinib derivative 1 (2e) effectively releases nitric oxide (NO) and increases the concentration of 3’,5’-cyclic guanosine monophosphate (cGMP), while maintaining senescent cell-clearing activity. This compound can be utilized for research into chronic ocular hypertension (COHT) glaucoma.

Images & Validation

Key Properties

CAS Number3079237-53-6
MW1188.69
FormulaC41H54ClN9O20S5
SMILESO=C(CCC(OCCN1CCN(CC1)C2=CC(NC3=NC=C(C(NC4=C(C)C=CC=C4Cl)=O)S3)=NC(C)=N2)=O)OCCOCCOC5=NON(=O)=C5S(=O)(C6=CC=CC=C6)=O.O=S(O)(C)=O.O=S(O)(C)=O.O=S(O)(C)=O

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Dasatinib derivative 1 (orb3028203)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%